Ronald M. Benoit, Jr., MD, presented “Cesium-131 Prostate Brachytherapy: A Single Institutional Long-Term Experience” for the Grand Rounds in Urology audience in May, 2020.
How to cite: Benoit Jr., Ronald M. “Cesium-131 Prostate Brachytherapy: A Single Institutional Long-Term Experience” May, 2020. Accessed Jul 2024. https://grandroundsinurology.com/cesium-131-prostate-brachytherapy-a-single-institutional-long-term-experience/
Cesium-131 Prostate Brachytherapy: A Single Institutional Long-Term Experience – Summary:
Ronald M. Benoit Jr., MD, Associate Professor, Clinical Vice Chair of Urology, Director of General Urology, and Chief of the Division of Community Urology at the University of Pittsburgh School of Medicine, describes the long-term results of a single institution cohort study investigating brachytherapy using Cesium-131 (Cs-131) in 669 prostate cancer patients. He goes on to describe the long-term impact on urinary function caused by using iodine and palladium implants, how study results using Cs-131 demonstrated shorter duration of urinary morbidity, and the relative 5- and 10-year biochemical-free recurrence rate among patients stratified at low, intermediate, and high risk levels.
ABOUT THE AUTHOR
Dr. Benoit is an Associate Professor and the Clinical Vice Chair of Urology, as well as the Director of General Urology and Chief of the Division of Community Urology, at the University of Pittsburgh School of Medicine in Pennsylvania. He is also Chief of Urology at the University of Pittsburgh Medical Center (UPMC) Mercy.
Dr. Benoit received his undergraduate degree in Natural Sciences from Johns Hopkins University in Baltimore, Maryland. He went on to earn his MD from the University of Pittsburgh, where he also served residencies in General Surgery and Urology.
Dr. Benoit has a broad array of interests in the field of urology, but his research focuses primarily on the assessment of healthcare quality and effectiveness. His clinical specialties include prostate brachytherapy, benign prostatic hyperplasia, and erectile dysfunction. His work has been widely published in peer-reviewed journals, including Urology, Canadian Journal of Urology, Journal of Urology, and Brachytherapy, among others.
